Svatek RS - Search Results

1

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.

Xylinas E, Cha EK, Sun M, Rink M, Trinh QD, Novara G, Green DA, Pycha A, Fradet Y, Daneshmand S, Svatek RS, Fritsche HM, Kassouf W, Scherr DS, Faison T, Crivelli JJ, Tagawa ST, Zerbib M, Karakiewicz PI, Shariat SF. Xylinas E, et al. Among authors: svatek rs. Br J Cancer. 2012 Nov 20;107(11):1826-32. doi: 10.1038/bjc.2012.464. Br J Cancer. 2012. PMID: 23169335 Free PMC article.

2

Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer.

Svatek R, Karakiewicz PI, Shulman M, Karam J, Perrotte P, Benaim E. Svatek R, et al. Eur Urol. 2006 Apr;49(4):666-74. doi: 10.1016/j.eururo.2005.11.032. Epub 2006 Jan 6. Eur Urol. 2006. PMID: 16423446

3

Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.

Svatek RS, Herman MP, Lotan Y, Casella R, Hsieh JT, Sagalowsky AI, Shariat SF. Svatek RS, et al. Cancer. 2006 Apr 15;106(8):1701-7. doi: 10.1002/cncr.21795. Cancer. 2006. PMID: 16541433 Free article.

4

Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy.

Shariat SF, Svatek RS, Kabbani W, Walz J, Lotan Y, Karakiewicz PI, Roehrborn CG. Shariat SF, et al. Among authors: svatek rs. BJU Int. 2008 Jan;101(2):232-7. doi: 10.1111/j.1464-410X.2007.07181.x. Epub 2007 Sep 13. BJU Int. 2008. PMID: 17868422

5

Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.

Svatek RS, Karam J, Karakiewicz PI, Gallina A, Casella R, Roehrborn CG, Shariat SF. Svatek RS, et al. J Urol. 2008 Feb;179(2):478-84; discussion 484. doi: 10.1016/j.juro.2007.09.037. J Urol. 2008. PMID: 18076936

6

Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.

Karam JA, Svatek RS, Karakiewicz PI, Gallina A, Roehrborn CG, Slawin KM, Shariat SF. Karam JA, et al. Among authors: svatek rs. Clin Cancer Res. 2008 Mar 1;14(5):1418-22. doi: 10.1158/1078-0432.CCR-07-0901. Clin Cancer Res. 2008. PMID: 18316564

7

Editorial comment on: Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

Shariat SF, Svatek RS. Shariat SF, et al. Among authors: svatek rs. Eur Urol. 2009 Mar;55(3):626-8. doi: 10.1016/j.eururo.2008.04.100. Epub 2008 May 15. Eur Urol. 2009. PMID: 18499336 No abstract available.

8

Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy.

Svatek RS, Karam JA, Roehrborn CG, Karakiewicz PI, Slawin KM, Shariat SF. Svatek RS, et al. Clin Cancer Res. 2008 Jun 1;14(11):3362-6. doi: 10.1158/1078-0432.CCR-07-4707. Clin Cancer Res. 2008. PMID: 18519764

9

Editorial comment on: Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience.

Svatek RS, Shariat SF. Svatek RS, et al. Eur Urol. 2009 Jan;55(1):185-6. doi: 10.1016/j.eururo.2008.07.019. Epub 2008 Jul 14. Eur Urol. 2009. PMID: 18640773 No abstract available.

10

Re: lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

Svatek R, Shariat SF. Svatek R, et al. Eur Urol. 2008 Sep;54(3):690-1. doi: 10.1016/j.eururo.2008.06.028. Eur Urol. 2008. PMID: 18792446 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page